Dr. Vivienne Marshall is Director of Research at NTI. Previously Dr. Marshall was P.I and Program Director at Stemnion, Inc, a start-up biotech company in Pittsburgh, PA. The company develops wound healing and regenerative medicine products. Dr. Marshall’s accomplishments included the research and development of Stemnion’s first product candidate for improved wound healing, and the subsequent preparation and submission of Stemnion’s first IND application to the FDA. Dr Marshall was P.I. of the company’s multiple USAMRMC awards for three years.

Prior to Stemnion, Dr. Marshall was Head of the Stem Cell Program at Revivicor, Inc (formerly PPL Therapeutics). Her program concentrated on the production of multipotent stem cells from hybrid cells, and their directed differentiation to cells of therapeutic importance. Before Revivicor, Dr. Marshall worked for 6 years with Dr. James Thomson, at the University of Wisconsin. The culmination of this work was the first published report of successful isolation and prolonged culture of human embryonic stem cells in 1998. Her responsibilities focused on both the isolation, culture and directed differentiation of primate embryonic stem cells; and assisted reproductive technologies in non-human primates.

Dr. Marshall earned her Ph.D. in Primate Embryology and Genetics from the University College, London in 1995. Her graduate work investigated embryology and genomic imprinting in a non-human primate model, the marmoset monkey. She holds a baccalaureate degree in Agricultural Science from Massey University in New Zealand.